Physician profile
Joseph L Tuma
NPI 1326081225
$61,151.93
in general payments reported to CMS, 2019-2025
32 companies · $4,055 in 2025
The $4,055 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,798 · 2020: $5,926 · 2021: $16K · 2022: $12K · 2023: $3,145 · 2024: $11K · 2025: $4,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,563 · Food and Beverage: $6,558 · Travel and Lodging: $3,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,562.50 |
| Food and Beverage | $6,558.25 |
| Travel and Lodging | $3,938.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $40,533.38 | 2021-2025 | Corevalve Evolut R, Turbohawk, Onyx Frontier |
| Medtronic Vascular, INC. | $12,847.37 | 2019-2020 | |
| Abbott Laboratories | $2,512.92 | 2019-2025 | Triclip, Pressurewire, Aveir |
| Edwards Lifesciences Corporation | $1,573.46 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $766.01 | 2020-2025 | Watchman Flx, General - Balloon Catheters, Jetstream Sc |
| Endologix LLC | $597.68 | 2020-2023 | Ovation Ix Iliac Stent Graft |
| Bard Peripheral Vascular, INC. | $304.77 | 2024-2025 | Rotarexs 6 F X 135 Cm, True Flow, Lutonix Drug Coated Balloon |
| W. L. Gore & Associates, INC. | $297.17 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Inspiremd LTD | $249.99 | 2025 | Cguard Prime Carotid Stent System |
| Abiomed | $229.60 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $221.89 | 2019-2021 | |
| Chiesi USA, INC. | $178.83 | 2019-2023 | Kengreal, Cleviprex |
| Pfizer INC. | $149.51 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $112.50 | 2025 | Winrevair |
| Biosense Webster, INC. | $107.75 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $94.67 | 2022 | |
| Atricure, INC. | $79.55 | 2023 | |
| Novartis Pharmaceuticals Corporation | $51.53 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.29 | 2019 | |
| Asahi Intecc USA, INC. | $36.08 | 2022 | |
| Cardiovascular Systems INC. | $28.64 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $24.88 | 2019-2020 | |
| Amgen INC. | $24.48 | 2019 | |
| Angiodynamics, INC. | $21.84 | 2020 | |
| Teleflex LLC | $16.55 | 2019 | |
| Biotronik INC. | $14.28 | 2019 | |
| Silk Road Medical, INC. | $13.22 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.09 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Tuma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.